- eNewsletter from American Peptide Company
May 2009 - vol.1 no.1
Welcome to the premiere issue of The Peptide Wire, the American Peptide Company's new semi-annual e-newsletter.
We have created this resource to keep you up-to-date on the latest news and events at American Peptide Company as our business evolves at a rapid pace.
Oligosaccharides are third-order essential biopolymers like nucleic acids and proteins.
Customer Spotlight:Our customers are continually developing innovative therapies to treat a multitude of chronic illnesses. Particularly in the area of cardiovascular ailments, peptide-based therapies have seen considerable success with a number of promising indications.
We recently partnered with Capstone Therapeutics to help the company develop novel therapies based on Capstone's thrombin peptide, Chrysalin (TP508 or rusalatide acetate).
Test your "Peptide IQ" and Win iPod nano and more!:Brush up on your industry and knowledge and take the "Peptide IQ" quiz. Winners receive gifts from American Peptide Company.
Simply send in your answers with your name and contact details. We will randomly select a winner from among the correct entries and send you your prize. Good luck!
Visit our Website: www.americanpeptide.com
May 19-21, Atlanta, GA
May 18-20, Las Vegas, NV
APS (American Peptide Symposium)
Jun 10-13, Bloomington, IN
Oct 13-15, Madrid, Spain
Booth # Hall 4/UPS 77
>> Other Shows
Director of Sales
>> Read more
Ask the Experts:
Q & A: Peptides and Good Manufacturing Practices (GMPs)
The Peptide Wire speaks with APC's resident experts, Patricia K. Haller, Ph.D., Director, GMP Production and Process Development and J. J. Jiang, Ph.D., VP of GMP Manufacturing on best practices in peptide GMP manufacturing.
>> Read more
In the News:
|This message was not sent unsolicited. Our records show that we have your permission to contact you via email. If you do not wish to receive further email messages from us, please reply to this message with "unsubscribe" as the subject line to email@example.com.|